Research Use Only · All products are strictly for in-vitro laboratory research purposes only and not for human or veterinary consumption.

PT141-10Purity not reported
Click to enlarge
Endocrine & Hormonal Signaling

PT-141

A synthetic cyclic melanocortin receptor agonist developed to analyze central nervous system receptor binding profiles. Targets central melanocortin receptors (primarily MC3R and MC4R) rather than peripheral vascular pathways. Evaluates downstream signaling mechanics of autonomic nervous system triggers and neurochemical pathways linked to behavioral responses.

Available sizes
⇄ Compare with related compounds →

Zelle to AFFLUENT SOCIETY LLC · paid orders ship the same business day with tracking · discreet outer box · COA by batch at /verify.

After manual payment confirmation; weekends and holidays ship the next business day. Published certificates only; some lots are still awaiting documentation.

Batch certificates

Certificate forthcoming for this lot

No certificate is currently published for this size; no publication date or fulfillment lot is assigned.

Quality & Verification
Source Report
Review available COA
Quantitative Assay
When reported in COA
Identity Method
As recorded by laboratory
Reported Purity
See exact lot report
3D Molecular Architecture · Sequence & Residues
Plate PT-141
7
Residues · modified or non-standard sequence
Formula
C50H68N14O10
Molecular weight
1,025.19 g/mol
Residues
7
CAS registry
189691-06-3

Idealized helix of the published sequence for laboratory reference; not a solved 3D structure or a claim about any lot.

Research Literature
Full Library →

Independent publications; not a claim about our material or about human use.

  1. Bremelanotide: an overview of clinical trials
    Kingsberg SA, et al. · Womens Health (Lond) · 2020 · PMID 32584654

Related in Endocrine & Hormonal Signaling

MT-1 10 mg research vial
Sold out

Endocrine & Hormonal Signaling

MT-1

$34.99

MT-2 10 mg research vial
Sold out

Endocrine & Hormonal Signaling

COA ✓
MT-2

$34.99